Recurrence after surgery remains a major cause of failure in head and neck squamous cell carcinoma (HNSCC), particularly for HPV-negative patients ... hazard ratio (HR) = 3.1, n = 73). When compared ...

Molbio Diagnostics in point-of-care molecular diagnostics, has introduced Truenat HPV-HR Plus, which enables expanded high-risk genotype detection. The chip-based RT-PCR test allows rapid and ...

There are over 100 types of human papillomavirus (HPV), and some can lead to different types of cancer, including cancer that affects the nose and throat. | Microbiology ...

In fact, 25 percent of cervical cancer diagnoses occur in women over the age of 65, and cervical cancers diagnosed in this ...

DATROWAY ® (datopotamab deruxtecan) has been approved in the European Union (EU) for the treatment of adult patients with unresectable or metastatic hormone receptor (HR) positive, HER2 negative ...

A recent report from HR platform Leapsome found 63% of U.S. HR leaders and 56% of global HR leaders who were surveyed said they are being pressured to force stricter return-to-office policies ...

The top-down shake-up came after the company’s lead assets at the time—autologous cell therapies being tested in HPV-positive tumors—showed meager effects in phase 1 trials, leading ...

Proteomics profiling of a pre-metastatic colorectal cancer cohort identifies four proteomics-based subtypes and highlights ...